Researchers have found a way to use a natural compound to stop diabetic retinopathy, one of the leading causes of blindness in the United States.
The discovery of the compound's function in inflammation and blood vessel formation related to eye disease means scientists can now develop new therapies to halt the disease, which affects as many as five million Americans with Type 1 and Type 2 diabetes.
Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness in American adults. It is caused by changes in blood vessels of the retina, the light-sensitive tissue at the back of the eye.